HAVANA, Nov.20th The Cuban-British joint venture BioFarma Innovations made its formal debut in the United Kingdom during an online seminar where Cuba’s advances in the biotechnology sector were shown, the embassy of the Caribbean country reported today.
In the event sponsored by the Caribbean Council, and where the advantages provided by this economic and commercial association were analyzed, the executive director of that organization, Chris Bennet, the co-president of the Cuba Initiative, Lord David Triesman, and the director of development participated. of the Cuban company Hebert Biotec SA, Merardo Pujol.
BioFarma Innovations, the result of an agreement between the Cuban company BioCubaFarma and the British company SG Innovations Ltd. was created last August, with the aim that the British Commonwealth and Europe have more expeditious access to the wide portfolio of patented medicines by the industry Cuban biotechnology, and the experience of the Caribbean island in the sector.
The seminar entitled “Bringing Cuban biopharmaceutical to patients around the world — a new Cuban-British joint venture”, also addressed the commercialization of pharmaceutical products in the world, the protection of intellectual property and the opportunities that exist to expand this relationship and bring Cuban medicines to many more patients around the world.
According to the Cuban embassy in London, the panellists emphasized the participation of Cuban science in confronting the pandemic, the successful use of Cuban biotechnological products in the fight against Covid-19 and the development by the Caribbean island of three vaccine candidates against the disease caused by the coronavirus SARS-CoV-2.
It was also highlighted that all these results have been achieved despite the tightening of the unilateral economic, commercial and financial blockade that the United States has maintained against the Caribbean country for 60 years.
As announced, the Cuban Chamber of Commerce and the United Kingdom Embassy in Havana will organize a similar seminar on December 11. (PL)